PEAK6 Investments’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3
Closed -$737 4901
2023
Q4
$539 Sell
3
-2,411
-100% -$456K ﹤0.01% 4119
2023
Q3
$481K Buy
+2,414
New +$571K ﹤0.01% 2422
2023
Q2
Sell
-13,096
Closed -$3.64M 4863
2023
Q1
$2.84M Buy
13,096
+2,567
+24% +$500K 0.01% 1039
2022
Q4
$2.16M Buy
10,529
+3,141
+43% +$794K 0.01% 1275
2022
Q3
$2.06M Buy
7,388
+2,563
+53% +$652K 0.01% 1532
2022
Q2
$922K Buy
+4,825
New +$852K ﹤0.01% 3186
2022
Q1
Sell
-6,723
Closed -$1.11M 6095
2021
Q4
$1.2M Buy
6,723
+6,602
+5,456% +$1.3M ﹤0.01% 2398
2021
Q3
$25K Buy
121
+118
+3,933% +$23.2K ﹤0.01% 4763
2021
Q2
$1K Sell
3
-4,022
-100% -$658K ﹤0.01% 5026
2021
Q1
$524K Sell
4,025
-4,080
-50% -$489K ﹤0.01% 3153
2020
Q4
$841K Buy
+8,105
New +$702K ﹤0.01% 2646

Other funds holding SWAV

PEAK6 Investments's SWAV Position: Q1 2024 in Review

PEAK6 Investments sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 3 shares — an estimated $737 sold.

PEAK6 Investments first reported a position in SWAV in Q4 2020 and held it in 11 quarters. The position peaked at $2.84M in Q1 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • PEAK6 Investments reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 3 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $737.
  • PEAK6 Investments first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • PEAK6 Investments's Shockwave Medical, Inc. Common Stock position peaked at $2.84M in Q1 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.